
Ciaxone S 500mg/250mg Injection
Marketer
Astam Health Care Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ciaxone S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration should strictly adhere to a healthcare provider's guidance. Consistent adherence to the prescribed dosage is crucial; prematurely halting treatment may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require immediate emergency care. Prior to commencing treatment, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals must consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are vital for optimal recovery. Monitoring may involve supplementary laboratory tests to assess treatment efficacy.
Primary Ingredients of Ciaxone S 500mg/250mg Injection
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Ciaxone S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ciaxone S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ciaxone S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ciaxone S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ciaxone S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Ciaxone S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, complements this action by neutralizing bacterial enzymes that would otherwise degrade Ceftriaxone, thus potentiating its antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of Ciaxone S 500mg/250mg Injection and alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ciaxone S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Ciaxone S 500mg/250mg Injection necessitates careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administration of Ciaxone S 500mg/250mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving is contraindicated should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Ciaxone S 500mg/250mg Injection use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
The 500mg/250mg Ciaxone S Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage changes for the 500mg/250mg Ciaxone S Injection are not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ciaxone S 500mg/250mg Injection :
Omit a scheduled Ciaxone S 500mg/250mg Injection? Seek your physician's advice.
Facts to Know About Ciaxone S 500mg/250mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Agents against infection |
